Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.60 |
| ▸ | LSS | P48449 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ICMT | O60725 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL795298 | 1.00 | TRPV1 (0.60) | TRPV1LSSALDH1A1ALOX15ICMT | |
| SCHEMBL11039509 | 0.98 | TRPV1 (0.59) | TRPV1LSSALOX15ICMT | |
| SCHEMBL11039511 | 0.98 | TRPV1 (0.59) | TRPV1LSSALOX15ICMT | |
| SCHEMBL12377556 | 0.98 | TRPV1 (0.59) | TRPV1LSSALOX15ICMT | |
| SCHEMBL1072281 | 0.88 | LSS (0.52) | TRPV1LSSICMT | |
| SCHEMBL10981272 | 0.88 | LSS (0.52) | TRPV1LSSICMT | |
| SCHEMBL10981275 | 0.88 | LSS (0.52) | TRPV1LSSICMT | |
| SCHEMBL1072282 | 0.88 | LSS (0.52) | TRPV1LSSICMT | |
| SCHEMBL12377555 | 0.88 | LSS (0.52) | TRPV1LSSICMT | |
| SCHEMBL19420736 | 0.88 | LSS (0.52) | TRPV1LSSALOX15ICMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130267571-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2013-10-10 | — | — | US | claimed |
| EP-2616056-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | Neuroquest Inc. (CA) | 2013-07-24 | — | — | EP | claimed |
| WO-2012034232-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2012-03-22 | — | — | WO | claimed |
| CN-106726659-B | High-oil-content cationic gel system and preparation method thereof | 广州市科能化妆品科研有限公司 | 2020-06-02 | — | — | CN | disclosed |
| US-20130267571-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2013-10-10 | — | — | US | disclosed |
| US-20130267571-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2013-10-10 | — | — | US | disclosed |
| US-20130267571-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2013-10-10 | — | — | US | disclosed |
| EP-2616056-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | Neuroquest Inc. (CA) | 2013-07-24 | — | — | EP | disclosed |
| WO-2012034232-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2012-03-22 | — | — | WO | disclosed |
| WO-2012034232-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | NEUROQUEST INC. (CA) | 2012-03-22 | — | — | WO | disclosed |
| EP-1797953-B1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2011-01-05 | — | — | EP | disclosed |
| EP-1609777-A1 | METHOD FOR PRODUCING OXYGEN-CONTAINING COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2005-12-28 | — | — | EP | disclosed |
| WO-2002017973-A2 | PREPARING STERILE ARTICLES FROM CERTAIN POLYMERS | OCCIDENTAL CHEMICAL CORPORATION (US) | 2002-03-07 | — | — | WO | disclosed |
| EP-0771778-B1 | Process for producing all trans-form polyprenols | KURARAY CO (JP) | 2001-01-10 | — | — | EP | disclosed |
| EP-1031551-A2 | A process for preparing all trans-form polyprenols | KURARAY CO., LTD. (JP) | 2000-08-30 | — | — | EP | disclosed |
| US-5714645-A | LENGTHENING 3,7-DIMETHYL-6-HYDROXY=7-OCTEN-1-OL BY REACTING WITH 2-METHYL-3,3-DIMETHOXY-1-BUTENE; REDUCING THE CARBONYL; HALOGENATING THE ALLYLHYDROXY; REACTING WITH A POLYISOPRENYL SULFONE AND DESULFONATING | KURARAY CO., LTD. (JP) | 1998-02-03 | — | — | US | disclosed |
| EP-0771778-A2 | Process for producing all trans-form polyprenols | KURARAY CO., LTD. (JP) | 1997-05-07 | — | — | EP | disclosed |
| US-4900847-A | Catalytic asymmetric epoxidation | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1990-02-13 | — | — | US | disclosed |
| US-4001339-A | INSECTICIDES | HOFFMANN-LA ROCHE INC. (US) | 1977-01-04 | — | — | US | disclosed |
| US-3944531-A | P-ALKOXY-BENZALDEHYDES, INSECTICIDE | HOFFMANN-LA ROCHE INC. (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130267571-A1 | TERPENOID ANALOGUES AND USES THEREOF FOR TREATING NEUROLOGICAL CONDITIONS | PMP22, PTGES, GGPS1 | TRPV1 8/4885LSS 16/4885ALDH1A1 1584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.